BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38370423)

  • 21. Analysis of
    Krasnyi AM; Gadzhieva LT; Kokoeva DN; Kosenko MG; Yarotskaya EL; Pavlovich SV; Ashrafyan LA; Sukhikh GT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical Hyperplasia.
    Pöschke P; Gass P; Krückel A; Keller K; Erber R; Hartmann A; Beckmann MW; Emons J
    Geburtshilfe Frauenheilkd; 2024 May; 84(5):470-476. PubMed ID: 38817597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy.
    Ga H; Taguchi A; Honjoh H; Nishijima A; Eguchi S; Miyamoto Y; Sone K; Mori M; Osuga Y
    Arch Gynecol Obstet; 2023 Nov; 308(5):1629-1634. PubMed ID: 37310452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical-grade endometrial cancer detection system
    Zhang X; Ba W; Zhao X; Wang C; Li Q; Zhang Y; Lu S; Wang L; Wang S; Song Z; Shen D
    Front Oncol; 2022; 12():1040238. PubMed ID: 36408137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Value of Shear Wave Elastography in Predicting the Risk of Endometrial Cancer and Atypical Endometrial Hyperplasia.
    Ma H; Yang Z; Wang Y; Song H; Zhang F; Yang L; Yan N; Zhang S; Cai Y; Li J
    J Ultrasound Med; 2021 Nov; 40(11):2441-2448. PubMed ID: 33433027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay.
    Zhou L; Meng Z; Wu Y; Zhu H; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():5-9. PubMed ID: 25461342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age.
    Okamura Y; Saito F; Takaishi K; Motohara T; Honda R; Ohba T; Katabuchi H
    Reprod Med Biol; 2017 Jan; 16(1):67-71. PubMed ID: 29259453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of artificial intelligence-based prescreening of large-bowel biopsies taken in the UK and Portugal: a retrospective cohort study.
    Bilal M; Tsang YW; Ali M; Graham S; Hero E; Wahab N; Dodd K; Sahota H; Wu S; Lu W; Jahanifar M; Robinson A; Azam A; Benes K; Nimir M; Hewitt K; Bhalerao A; Eldaly H; Raza SEA; Gopalakrishnan K; Minhas F; Snead D; Rajpoot N
    Lancet Digit Health; 2023 Nov; 5(11):e786-e797. PubMed ID: 37890902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
    Gonthier C; Piel B; Touboul C; Walker F; Cortez A; Luton D; Daraï E; Koskas M
    Anticancer Res; 2015 Dec; 35(12):6799-804. PubMed ID: 26637899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women.
    Bagepalli Srinivas S; Kubakaddi SS; Polisetti S; Amber S; Guruvare S; Vaman Pai M
    Int J Womens Health; 2020; 12():883-891. PubMed ID: 33149699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Zaino RJ; Kauderer J; Trimble CL; Silverberg SG; Curtin JP; Lim PC; Gallup DG
    Cancer; 2006 Feb; 106(4):804-11. PubMed ID: 16400640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy.
    Chen J; Cao D; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Shen K
    Front Oncol; 2021; 11():738370. PubMed ID: 34568074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
    Minig L; Franchi D; Boveri S; Casadio C; Bocciolone L; Sideri M
    Ann Oncol; 2011 Mar; 22(3):643-649. PubMed ID: 20876910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.
    Hirata T; Kondo E; Magawa S; Kubo-Kaneda M; Nii M; Yoshida K; Maezawa T; Tabata T; Ikeda T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3219-3225. PubMed ID: 36054237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of treatment of atypical endometrial hyperplasia].
    Tabakman IuIu; Al-Khalabi A; Vasil'eva IA
    Akush Ginekol (Mosk); 1987 Jul; (7):35-7. PubMed ID: 3688327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.
    Tamauchi S; Kajiyama H; Utsumi F; Suzuki S; Niimi K; Sakata J; Mizuno M; Shibata K; Kikkawa F
    J Obstet Gynaecol Res; 2018 Jan; 44(1):151-156. PubMed ID: 29121428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer.
    Guan J; Chen XJ
    Front Endocrinol (Lausanne); 2022; 13():1041535. PubMed ID: 36387903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature.
    Rakha E; Wong SC; Soomro I; Chaudry Z; Sharma A; Deen S; Chan S; Abu J; Nunns D; Williamson K; McGregor A; Hammond R; Brown L
    Am J Surg Pathol; 2012 Nov; 36(11):1683-90. PubMed ID: 23073327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.